Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,962 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Chelation therapy for ischemic heart disease: a randomized controlled trial.
Knudtson ML, Wyse DG, Galbraith PD, Brant R, Hildebrand K, Paterson D, Richardson D, Burkart C, Burgess E; Program to Assess Alternative Treatment Strategies to Achieve Cardiac Health (PATCH) Investigators. Knudtson ML, et al. Among authors: richardson d. JAMA. 2002 Jan 23-30;287(4):481-6. doi: 10.1001/jama.287.4.481. JAMA. 2002. PMID: 11798370 Clinical Trial.
Protocol of a decisional intervention for older adults with newly diagnosed acute myeloid leukemia and their caregivers: UR-GOAL 3.
Loh KP, Ng QMR, Mohile SG, Norton S, Epstein RM, Sohn MB, Richardson D, Jamy O, Hedjri SM, Blumberg R, Nafis L, Jensen-Battaglia M, Wang Y, Mendler J, Liesveld J, Huselton EJ, Rodenbach R, Moore J, Maguire C, Buechler SM, Hodges S, Klepin HD. Loh KP, et al. Among authors: richardson d. J Geriatr Oncol. 2025 Jan 18:102187. doi: 10.1016/j.jgo.2025.102187. Online ahead of print. J Geriatr Oncol. 2025. PMID: 39828449
Diffusion changes in minimally invasive parafascicular approach for deep-seated tumours: impact on clinical outcomes.
Awan M, Elshalakany A, Kalaitzoglou D, Kalyal N, Sinha S, Perera A, Wroe Wright O, Gallagher MJ, Richardson D, Elhag A, Marchi F, Abougamil A, Silva M, Oviedova A, Patel S, Mirallave-Pescador A, Diaz-Baamonde A, Bleil C, Zebian B, Gullan R, Ashkan K, Vergani F, Bhangoo R, Lavrador JP. Awan M, et al. Among authors: richardson d. Neurosurg Rev. 2025 Jan 18;48(1):63. doi: 10.1007/s10143-024-03160-y. Neurosurg Rev. 2025. PMID: 39826028
First-in-human phase I trial of the bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, SL-172154 in patients with platinum-resistant ovarian cancer.
Lakhani NJ, Stewart D, Richardson DL, Dockery LE, Van Le L, Call J, Rangwala F, Wang G, Ma B, Metenou S, Huguet J, Offman E, Pandite L, Hamilton E. Lakhani NJ, et al. Among authors: richardson dl. J Immunother Cancer. 2025 Jan 11;13(1):e010565. doi: 10.1136/jitc-2024-010565. J Immunother Cancer. 2025. PMID: 39800375 Free PMC article. Clinical Trial.
A trial of radiolabeled antibody yttrium-90-FF-21101 for the treatment of advanced ovarian and other cancers.
Mahalingam D, Owonikoko TK, Delpassand E, Mulcahy MF, Kalyan A, Ulahannan S, Cheung K, Izumi Y, Johansen M, Madden T, Shimoyama S, Subach RA, Suzuki T, Wages DS, Wheeler C, Richardson DL. Mahalingam D, et al. Among authors: richardson dl. Cancer. 2025 Jan 1;131(1):e35680. doi: 10.1002/cncr.35680. Cancer. 2025. PMID: 39748726 Free PMC article. Clinical Trial.
3,962 results